Why target apoptosis in cancer treatment?

Molecular Cancer Therapeutics

Volumn 2, Issue 6, 2003, Pages 573-580

  Kasibhatla, Shailaja ^a   Tseng, Ben ^a  

^a Maxim Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; DISEASE COURSE; HUMAN; METABOLISM; MITOCHONDRION; NEOPLASM; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; DISEASE PROGRESSION; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 1542322900     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (91)

1. Shapiro, G. I., and Harper, J. W. Anticancer drug targets: cell cycle and checkpoint control. J. Clin. Investig., 104: 1645-1653, 1999. (Pubitemid 30053178)
2. Kroemer, G., Dallaporta, B., and Resche-Rigon, M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol., 60: 619-642, 1998. (Pubitemid 28157889)
3. Henson, P. M., Bratton, D. L., and Fadok, V. A. Apoptotic cell removal. Curr. Biol., 11: R795-R805, 2001. (Pubitemid 32931008)
4. Green, D. R., and Evan, G. I. A matter of life and death. Cancer Cell, 1: 19-30, 2002. (Pubitemid 41039172)
5. Evan, G. I., and Vousden, K. H. Proliferation, cell cycle and apoptosis in cancer. Nature (Lond.), 411: 342-348, 2001. (Pubitemid 32467043)
6. Nicholson, D. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ., 11: 1028-1042, 1999.
7. Stennicke, H., and Salvesen, G. Caspases: controlling intracellular signals by protease zymogen activation. Biochim. Biophys. Acta, 1477: 299-306, 2000. (Pubitemid 30119908)
8. Hu, S., Snipas, S. J., Vincenz, C., Salvesen, G., and Dixit, V. M. Caspase-14 is a novel developmentally regulated protease. J. Biol. Chem., 273: 29648-29653, 1998. (Pubitemid 28509974)
9. Ahmad, M., Srinivasula, S. M., Hegde, R., Mukattash, R., Fernandes-Alnemri, T., and Alnemri, E. S. Identification and characterization of murine caspase-14, a new member of the caspase family. Cancer Res., 58: 5201-5205, 1998. (Pubitemid 28521183)
10. Locksley, R. M., Killeen, N., and Lenardo, M. J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell, 104: 487-501, 2001. (Pubitemid 32201945)
11. Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K., Johnson, M., Lynch, D., Tsien, R. Y., and Lenardo, M. J. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science (Wash. DC), 288: 2354-2357, 2000. (Pubitemid 30448157)
12. Chan, F. K., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., and Lenardo, M. J. A domain in TNF receptors that mediates ligand-independent recpetor assembly and signaling. Science (Wash. DC), 288: 2351-2354, 2000. (Pubitemid 30448156)
13. Baud, V., and Karin, M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol., 11: 372-377, 2001. (Pubitemid 32900529)
14. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S. J. NF-κB anti-apoptosis induction of TRAF-1 and TRAF-2 and c-IAP1 and c-IAP2 to suppress capase-8 activation. Science (Wash. DC), 281: 1680-1683, 1998.
15. Jiang, Y., Woronicz, J. D., Liu, W., and Goeddel, D. V. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science (Wash. DC), 283: 543-546, 1999.
16. MacDonald, G., Shi, L., Vande Velde, C., Lieberman, J., and Greenberg, A. Mitochondria-dependent and -independent regulation of granzyme B-induced apoptosis. J. Exp. Med., 189: 131-144, 1999.
17. Waterhouse, N., Goldstein, J., von Ahsen, O., Schuler, M., Newmeyer, D., and Green, D. Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J. Cell Biol., 153: 319-328, 2001. (Pubitemid 34280218)
18. Martinou, J., and Green, D. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell. Biol., 2: 63-67, 2001. (Pubitemid 33676963)
19. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Wash. DC), 281: 1309-1312, 1998. (Pubitemid 28406816)
20. Gross, A., McDonnell, J. M., and Korsmeyer, S. J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev., 13: 1899-1911, 1999. (Pubitemid 29407357)
21. Zou, H., Henzel, W., Liu, X., Lutschg, A., and Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 90: 405-413, 1997. (Pubitemid 27347231)
22. Zou, H., Li, Y., Liu, X., and Wang, X. An APAF-1•cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem., 274: 11549-11556, 1999.
23. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S., Ahmad, M., Alnemri, E., and Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91: 479-489, 1997. (Pubitemid 27508237)
24. Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., and Alnemri, E. S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell, 1: 949-957, 1998. (Pubitemid 128379256)
25. Susin, S., Lorenzo, H., Zamzami, N., Marzo, I., Snow, B., Brothers, G., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D., Aebersold, R., Siderovski, D., Penninger, J., and Kroemer, G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (Lond.), 397: 441-446, 1999.
26. Li, L., Luo, X., and Wang, X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature (Lond.), 412: 95-99, 2001. (Pubitemid 32851517)
27. Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K., and Takahashi, R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell, 8: 613-621, 2001. (Pubitemid 32946938)
28. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102: 33-42, 2000.
29. Verhagen, A., M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., and Vaux, D. L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 102: 43-53, 2000.
30. Xanthoudakis, S., Roy, S., Rasper, D., Hennessey, T., Aubin, Y., Cassady, R., Tawa, P., Ruel, R., Rosen, A., and Nicholson, D. Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J., 18: 2049-2056, 1999. (Pubitemid 29179162)
31. Samali, A., Cai, J., Zhivotovsky, B., Jones, D., and Orrenius, S. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. EMBO J., 18: 2040-2048, 1999. (Pubitemid 29179161)
32. Mancini, M., Nicholson, D. W., Roy, S., Thornberry, N. A., Peterson, E. P., Casciola-Rosen, L. A., and Rosen, A. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J. Cell Biol., 140: 1485-1495, 1998. (Pubitemid 28152996)
33. Eskes, R., Desagher, S., Antonsson, B., and Martinou, J. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol., 20: 929-935, 2000. (Pubitemid 30044230)
34. Desagher, S., Osen-Sand, A., Nichols, A., Eskes, R., Montessuit, S., Lauper, S., Maundrell, K., Antonsson, B., and Martinou, J. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol., 144: 891-901, 1999. (Pubitemid 29238966)
35. L sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell, 8: 705-711, 2001.
36. Vieira, H., Boya, P., Cohen, I., El Hamel, C., Haouzi, D., Druillenec, S., Belzacq, A., Brenner, C., Roques, B., and Kroemer, G. Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-XL. Oncogene, 21: 1963-1977, 2002. (Pubitemid 34270885)
37. Wolter, K., Hsu, Y., Smith, C., Nechushtan, A., Xi, X., and Youle, R. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol., 39: 1281-1292, 1997. (Pubitemid 27523214)
38. Antonsson, B., Conti, F., Ciavatta, A., Montessuit, S., Lewis, S., Martinou, I., Bernasconi, L., Bernard, A., Mermod, J., Mazzei, G., Maundrell, K., Gambale, F., Sadoul, R., and Martinou, J. Inhibition of Bax channel-forming activity by Bcl-2. Science (Wash. DC), 277: 370-372, 1997. (Pubitemid 27450709)
39. Marzo, I., Brenner, C., Zamzami, N., Jurgensmeier, J., Susin, S., Vieira, H. L., Prevost, M., Xie, Z., Matsuyama, S., Reed, J., and Kroemer, G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science (Wash. DC), 281: 2027-2031, 1998. (Pubitemid 28475490)
40. Shimizu, S., Narita, M., and Tsujimoto, Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature (Lond.), 399: 483-487, 1999. (Pubitemid 29258855)
41. Kuwana, T., Mackey, M., Perkins, G., Ellisman, M., Latterich, M., Schneiter, R., Green, D., and Newmeyer, D. Bid, bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell, 111: 331-342, 2002. (Pubitemid 35341388)
42. Li, B., and Dou, Q. P. Bax degradation by the ubiquitin/proteasome- dependent pathway: involvement in tumor survival and progression. Proc. Natl. Acad. Sci. USA, 97: 3850-3855, 2000. (Pubitemid 30226050)
43. Cregan, S., Fortin, A., MacLaurin, J. G., Callaghan, S. M., Cecconi, F., Yu, S. W., Dawson, T. M., Dawson, V. L., Park, D. S., Kroemer, G., and Slack, R. S. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol., 158: 507-517, 2002. (Pubitemid 34851709)
44. Haraguchi, M., Torii, S., Matsuzawa, S., Xie, Z., Kitada, S., Krajewski, S., Yoshida, H., Mak, T. W., and Reed, J. C. Apoptotic protease activating factor 1 (Apaf-1)-independent cell death suppression by Bcl-2. J. Exp. Med., 191: 1709-1720, 2000. (Pubitemid 30332454)
45. Sperandio, S. I., de Belle, I., and Bredesen, D. E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA, 97: 14376-14381, 2000. (Pubitemid 32016583)
46. Rao, R., Castro-Obregon, S., Frankowski, H., Schuler, M., Stoka, V., del Rio, G., Bredesen, D. E., and Ellerby, H. M. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J. Biol. Chem., 277: 21836-21842, 2002. (Pubitemid 34952336)
47. Deveraux, Q., and Reed, J. IAP family proteins: suppressors of apoptosis. Genes Dev., 13: 239-252, 1999. (Pubitemid 29095796)
48. Suzuki, Y., Nakabayashi, Y., and Takahashi, R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. USA, 98: 8662-8667, 2001. (Pubitemid 32678084)
49. Chai, J. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature (Lond.), 406: 855-862, 2000. (Pubitemid 30664254)
50. Beere, H. M., Wolf, B. B., Cain, K., Kuwana, T., Tailor, P., Morimoto, R. I., Cohen, G., and Green, D. R. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol., 2: 469-475, 2000.
51. Chen, Y. R., and Tan, T. H. The c-Jun N-terminal kinase pathway and apoptotic signaling. Int. J. Oncol., 16: 651-662, 2000.
52. Davis, R. J. Signal transduction by the JNK group of MAP kinases. Cell, 103: 239-252, 2000.
53. Fuchs, S. Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S. N., and Ronai, Z. JNK targets p53 ubiquitination and degradation in non-stressed cells. Genes Dev., 12: 2658-2663, 1998. (Pubitemid 28420646)
54. Fuchs, S. Y., Adler, V., Pincus, M. R., and Ronai, Z. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA, 95: 10541-10546, 1998. (Pubitemid 28413103)
55. Noguchi, K., Kitanaka, C., Tamana, H., Kokubu, A., Mochizuki, T., and Kuchino, Y. Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase. J. Biol. Chem., 274: 32580-32587, 1999. (Pubitemid 129535283)
56. Yamamoto, K., Ichijo, H., and Korsmeyer, S. J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G2/M. Mol. Cell. Biol., 19: 8469-8478, 1999. (Pubitemid 30414041)
57. Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., and Davis, R. J. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science (Wash. DC), 288: 870-874, 2000. (Pubitemid 30257738)
58. Datta, S. D., Brunet, A., and Greenberg, M. Cellular survival: a play in three Akts. Genes Dev., 13: 2905-2927, 1999.
59. Zha, J., Harada, E., Yang, J., Jockel, J., and Korsmeyer, S. J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell, 87: 619-628, 1996. (Pubitemid 26386936)
60. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96: 857-868, 1999. (Pubitemid 29165088)
61. Dikers, P. F., Medema, J-H., Lammes, J., Koenderman, L., and Coffer, P. J. Expression of the pro-apoptotic family member Bim is regulated by the Forkhead transcription factor, FKMR-L1. Curr. Biol., 10: 1201-1204, 2000.
62. Kane, L. P., Shapiro, V. S., Stokoe, D., and Weiss, A. Induction of NF-κB by the Akt/PKB kinase. Curr. Biol., 9: 601-604, 1999.
63. Zong, W-X., Edelstein, L. C., Chen, C., Bash, J., and Gelinas, C. The pro-survival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNF-α-induced apoptosis. Genes Dev., 13: 382-387, 1999. (Pubitemid 29108753)
64. You, M., Ku, P. T., Hirdlickova, R., and Bose, H. R. J. ch-IAP1, a member of the the inhibitor-of-apoptosis protein family, is a mediater of the antiapoptotic activity of the v-Rel oncoprotein. Mol. Cell. Biol., 17: 7328-7341, 1997. (Pubitemid 27505962)
65. Rayet, B., and Gelinas, C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene, 18: 6938-6947, 1999.
66. Prendergast, G. Mechanisms of apoptosis by c-Myc. Oncogene, 18: 2967-2987, 1999. (Pubitemid 29276537)
67. Kasibhatla, S., Beere, H., Brunner, T., Echeverri, F., and Green, D. A "non-canonical" DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc. Curr. Biol., 10: 1205-1208, 2000.
68. Sher, C. J., and Weber, J. D. The ARF/p53 pathway. Curr. Opin. Genet. Dev., 10: 94-99, 2000. (Pubitemid 30113711)
69. Brunner, T., Kasibhatla, S., Pinkoski, M., Frutschi, C., Yoo, N., Echeverri, F., Mahboubi, A., and Green, D. Expression of Fas ligand in activated T cells is regulated by c-Myc. J. Biol. Chem., 275: 9767-9772, 2000. (Pubitemid 30185211)
70. Juin, P., Hueber, A. O., Littlewood, T., and Evan, G. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev., 13: 1367-1381, 1999. (Pubitemid 29270243)
71. Juin, P., Hunt, A., Littlewood, T., Griffiths, B., Swigart, L., Korsmeyer, S., and Evan, G. c-Myc functionally cooperates with Bax to induce apoptosis, Mol. Cell. Biol., 22: 6158-6169, 2002. (Pubitemid 34857836)
72. Urist, M., and Prives, C. p53 leans on its siblings. Cancer Cell, 1: 311-313, 2002. (Pubitemid 41039132)
73. Vousden, K., and Lu, X. Live or let die: the cell's response to p53. Nat. Rev. Cancer, 2: 594-604, 2002. (Pubitemid 37328926)
74. Ryan, K., Phillips, A., and Vousden, K. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol., 13: 332-337, 2001. (Pubitemid 32429498)
75. Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., and Tanaka, N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science (Wash. DC), 288: 1053-1058, 2000. (Pubitemid 30324238)
76. Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., and Taya, Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell, 102: 849-862, 2000.
77. Lin, Y., Ma, W., and Benchimol, S. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat. Genet., 26: 122-127, 2000.
78. Gallagher, W. M., and Brown, R. p53-orientated cancer therapies: current progress. Ann. Oncol., 10: 139-150, 1999. (Pubitemid 29113172)
79. Selivanova, G., Iotsova, V., and Okan, I. Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nat. Med., 3: 632-638, 1997. (Pubitemid 27264972)
80. Abarzua, P., Lsardo, J. E., and Gubler, M. L. Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53. Cancer Res., 55: 3490-3494, 1995.
81. Foster, B. Pharmacological rescue of mutant p53 confomation and function. Science (Wash. DC), 286: 2507-2510, 1999.
82. Bottger, A., Bottger, V., and Sparks, A. Design of a synthetic Mdm-2-binding mini protein that activates the p53 response in vivo. Curr. Biol., 7: 860-869, 1997. (Pubitemid 27493125)
83. Baell, J., and Huang, D. Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs. Biochem. Pharmacol., 64: 851-863, 2002. (Pubitemid 35232259)
84. Webb, A., Cunningham, D., Cotter, F., Clarke, P., DdiStefano, F., Ross, P., Corbo, M., and Dziewanowska, Z. Bcl-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet, 349: 1137-1141, 1997. (Pubitemid 27168548)
85. Jansen, B., Schlagbauer-Wadl, H., Brown, B., Bryan, R., van Elsas, A., Muller, M., Wolff, K., Eichler, H., and Pehamberger, H. bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat. Med., 4: 232-234, 1998. (Pubitemid 28137379)
86. Piche, A., Grim, J., Rancourt, C., Gomez-Navarro, J., Reed, J. C., and Curiel, D. T. Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7. Cancer Res., 58: 2134-2140, 1998. (Pubitemid 28232899)
87. Degterev, A. Identification of small molecule inhibitors of interaction between the BH3 domain and BCL-XL. Nat. Cell Biol., 3: 173-182, 2001. (Pubitemid 32118371)
88. Huang, Z. Bcl-2 family proteins as targets for anticancer drug design. Oncogene, 19: 6627-6631, 1999.
89. Tzung, S. Antimycin A mimics a cell death-inducing Bcl-2 homology domain 3. Nat. Cell Biol., 3: 183-192, 2001.
90. Druker, B., Tamura, S., Buchdunger, E., Ohno, S., Segal, G., Fanning, S., Zimmermann, J., and Lydon, N. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med., 2: 561-566, 1996.
91. Mahon, F., Deininger, M., Schultheis, B., Chabrol, J., Reiffers, J., Goldman, J., and Melo, J. Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance. Blood, 96: 1070-1079, 2000. (Pubitemid 30616875)